SUBSCRIBE
SUBSCRIBE
Events

20th Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech

ABOUT THE EVENT

Date: March 18, 2026 - March 19, 2026
Event Location: New Jersey, New Jersey

Attend the Marcus Evans 20th Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech conference taking place in New Jersey between 18-19 March and explore how leading pharma and biotech organizations are strengthening portfolio decision-making frameworks amid rising regulatory pressures, investment constraints, and scientific uncertainty.

This event will examine evolving expectations around governance discipline, cross-functional alignment and evidence-based valuation, alongside how teams are embedding advanced analytics and AI to enhance forecasting, scenario modelling and risk assessment. Sessions will also address the operational realities of resource bottlenecks, shifting strategic priorities and accelerated development timelines, while senior leaders share best practices for future-proofing portfolios against market disruption and sustaining long-term R&D competitiveness.

Attending This Premier marcus evans Conference Will Enable You to:

• Build an Enterprise Portfolio Decision Framework for Maximum Value and Impact
• Strengthen communication, transparency, and cross-functional engagement to drive unified portfolio execution
• Establish robust data foundations to deliver reliable, actionable portfolio insights
• Enhance external partnerships and co-development collaboration to support portfolio growth
• Advance prioritization methodologies to balance short-term wins with long-term innovation
• Build organizational agility to support transformation, growth, and future readiness

Best Practices and Case Studies from:

· Erin Mulrooney, Director, Portfolio Management, Daiichi Sankyo
· Vinod V Nair, Director, Strategy & Program Management, Innovation Lab, Novartis
· Michael Ferrante, Executive Director, Business Analytics, Regulatory Affairs and Clinical Safety, Merck
· Saeid Yazdani, Sr. Director Project, Program, and Portfolio Management, argenx
· Erika L. Fareed, Senior Director, Strategy Implementation & Business Transformation, AstraZeneca
· Glen Stambone, Director, Project Management Office, Boehringer Ingelheim

Biospace members are entitled to $200 discount! For more information please contact: Ria Kiayia, Marketing Manager, Digital Media and PR at riak@marcusevanscy.com or visit: https://bit.ly/4kEUiSf

Register now!
New Jersey Generative AI Data
MORE EVENTS
Events
Register: Lean Derisking: Taking Your Proof of Concept to the Clinic
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.
Tuesday, February 24, 2026 12–1pm EST
 · 
Virtual
Events
Register: The Future is Collaborative: Transforming Clinical Trials
In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.
Monday, March 2, 2026 11am–12pm EST
 · 
Virtual
Events
Register: Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium
Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.
Tuesday, March 17, 2026 1–2pm EDT
 · 
Virtual
More Events